GlassScriptPhysician profile
Jeffrey Mark Pearson
NPI 1710364948
$4,313.00
in general payments reported to CMS, 2019-2025
25 companies · $1,001 in 2025
The $1,001 reported for 2025 was more than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $538 · 2021: $970 · 2022: $907 · 2023: $300 · 2024: $597 · 2025: $1,001.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,899.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,898.61 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $1,999.30 | 2020-2025 | Mako, Gamma, Aequalis Ascend Flex |
| Smith+Nephew, INC. | $446.72 | 2021-2025 | Na, N/A, Intellio Link Werewolf |
| Microport Orthopedics INC | $310.26 | 2021 | |
| Depuy Synthes Sales INC. | $257.90 | 2020-2024 | Motoband, Minibunion, Hammerlock |
| Medacta USA, INC. | $211.17 | 2022-2025 | Gmk Sphere |
| Mimedx Group, INC. | $141.09 | 2024 | |
| Exactech, INC. | $120.73 | 2020 | |
| Convatec INC. | $113.93 | 2023-2025 | |
| Curonix LLC | $107.46 | 2025 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Orthofix Medical, INC. | $76.00 | 2020 | |
| Omnilife Science, INC | $74.17 | 2020 | |
| Orthalign INC | $73.43 | 2024 | Orthalign Plus |
| Innovation Technologies INC | $63.05 | 2024-2025 | Irrisept |
| Ferring Pharmaceuticals INC. | $57.14 | 2022-2025 | Euflexxa |
| Vertex Pharmaceuticals Incorporated | $34.07 | 2024-2025 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organogenesis INC. | $34.01 | 2023 | Puraply |
| Kci USA, INC. | $31.23 | 2021-2022 | |
| Medical Device Business Services, INC. | $26.88 | 2021 | |
| Becton, Dickinson and Company | $26.43 | 2025 | Arista |
| Amgen INC. | $22.71 | 2023 | Evenity, Prolia |
| Pacira Pharmaceuticals Incorporated | $21.72 | 2021 | |
| Sanara Medtech INC. | $18.01 | 2023 | Celleraterx |
| Abbvie INC. | $16.92 | 2024 | |
| Avanos Medical | $14.49 | 2023 | Trivisc Sodium Hyaluronate |
| Baudax Bio INC. | $14.18 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jeffrey Pearson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.